Your browser doesn't support javascript.
loading
Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial.
Leth, Steffen; Schleimann, Mariane H; Nissen, Sara K; Højen, Jesper F; Olesen, Rikke; Graversen, Mette E; Jørgensen, Sofie; Kjær, Anne Sofie; Denton, Paul W; Mørk, Alejandra; Sommerfelt, Maja A; Krogsgaard, Kim; Østergaard, Lars; Rasmussen, Thomas A; Tolstrup, Martin; Søgaard, Ole Schmeltz.
Afiliação
  • Leth S; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark; Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark. Electronic address: steffenleth@gmail.com.
  • Schleimann MH; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark; Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Nissen SK; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark; Institute of Biomedicine, Aarhus University, Aarhus, Denmark.
  • Højen JF; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark; Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Olesen R; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
  • Graversen ME; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark; Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Jørgensen S; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark; Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Kjær AS; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark; Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Denton PW; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark; Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Mørk A; Bionor Pharma, Oslo, Norway.
  • Sommerfelt MA; Bionor Pharma, Oslo, Norway.
  • Krogsgaard K; Bionor Pharma, Oslo, Norway.
  • Østergaard L; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark; Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Rasmussen TA; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
  • Tolstrup M; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark; Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Søgaard OS; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark; Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark. Electronic address: olesoega@rm.dk.
Lancet HIV ; 3(10): e463-72, 2016 10.
Article em En | MEDLINE | ID: mdl-27658863
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fator Estimulador de Colônias de Granulócitos e Macrófagos / HIV-1 / Vacinas contra a AIDS / Depsipeptídeos Limite: Adolescent / Adult / Humans / Male Idioma: En Revista: Lancet HIV Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fator Estimulador de Colônias de Granulócitos e Macrófagos / HIV-1 / Vacinas contra a AIDS / Depsipeptídeos Limite: Adolescent / Adult / Humans / Male Idioma: En Revista: Lancet HIV Ano de publicação: 2016 Tipo de documento: Article